Venous Thromboembolism Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Venous Thromboembolism Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Venous Thromboembolism Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Venous Thromboembolism Therapeutics Overall Market Size
2.1 Global Venous Thromboembolism Therapeutics Market Size: 2021 VS 2028
2.2 Global Venous Thromboembolism Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Venous Thromboembolism Therapeutics Players in Global Market
3.2 Top Global Venous Thromboembolism Therapeutics Companies Ranked by Revenue
3.3 Global Venous Thromboembolism Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Venous Thromboembolism Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Venous Thromboembolism Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Venous Thromboembolism Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Venous Thromboembolism Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Venous Thromboembolism Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Venous Thromboembolism Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Factor Xa Inhibitors
4.1.3 Direct Thrombin Inhibitors
4.1.4 Heparin
4.1.5 Vitamin K Antagonists
4.1.6 Other
4.2 By Type - Global Venous Thromboembolism Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Venous Thromboembolism Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Venous Thromboembolism Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Venous Thromboembolism Therapeutics Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Other
5.2 By Application - Global Venous Thromboembolism Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Venous Thromboembolism Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Venous Thromboembolism Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Venous Thromboembolism Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Venous Thromboembolism Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Venous Thromboembolism Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Venous Thromboembolism Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Venous Thromboembolism Therapeutics Revenue, 2017-2028
6.3.2 US Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.3.3 Canada Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.3.4 Mexico Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Venous Thromboembolism Therapeutics Revenue, 2017-2028
6.4.2 Germany Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.4.3 France Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.4.4 U.K. Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.4.5 Italy Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.4.6 Russia Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.4.8 Benelux Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Venous Thromboembolism Therapeutics Revenue, 2017-2028
6.5.2 China Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.5.3 Japan Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.5.4 South Korea Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.5.6 India Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Venous Thromboembolism Therapeutics Revenue, 2017-2028
6.6.2 Brazil Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.6.3 Argentina Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Venous Thromboembolism Therapeutics Revenue, 2017-2028
6.7.2 Turkey Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.7.3 Israel Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Venous Thromboembolism Therapeutics Market Size, 2017-2028
6.7.5 UAE Venous Thromboembolism Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Venous Thromboembolism Therapeutics Major Product Offerings
7.1.4 Johnson & Johnson Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Venous Thromboembolism Therapeutics Major Product Offerings
7.2.4 Sanofi Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Venous Thromboembolism Therapeutics Major Product Offerings
7.3.4 Boehringer Ingelheim Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 Daiichi Sankyo
7.4.1 Daiichi Sankyo Corporate Summary
7.4.2 Daiichi Sankyo Business Overview
7.4.3 Daiichi Sankyo Venous Thromboembolism Therapeutics Major Product Offerings
7.4.4 Daiichi Sankyo Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Daiichi Sankyo Key News
7.5 Bristol-Myers Squibb (BMS)
7.5.1 Bristol-Myers Squibb (BMS) Corporate Summary
7.5.2 Bristol-Myers Squibb (BMS) Business Overview
7.5.3 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Major Product Offerings
7.5.4 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Bristol-Myers Squibb (BMS) Key News
7.6 Bayer HealthCare
7.6.1 Bayer HealthCare Corporate Summary
7.6.2 Bayer HealthCare Business Overview
7.6.3 Bayer HealthCare Venous Thromboembolism Therapeutics Major Product Offerings
7.6.4 Bayer HealthCare Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Bayer HealthCare Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Venous Thromboembolism Therapeutics Major Product Offerings
7.7.4 Pfizer Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Pfizer Key News
7.8 Leo Pharma
7.8.1 Leo Pharma Corporate Summary
7.8.2 Leo Pharma Business Overview
7.8.3 Leo Pharma Venous Thromboembolism Therapeutics Major Product Offerings
7.8.4 Leo Pharma Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Leo Pharma Key News
7.9 Portola Pharmaceuticals
7.9.1 Portola Pharmaceuticals Corporate Summary
7.9.2 Portola Pharmaceuticals Business Overview
7.9.3 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Major Product Offerings
7.9.4 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Portola Pharmaceuticals Key News
7.10 ThromboGenics
7.10.1 ThromboGenics Corporate Summary
7.10.2 ThromboGenics Business Overview
7.10.3 ThromboGenics Venous Thromboembolism Therapeutics Major Product Offerings
7.10.4 ThromboGenics Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.10.5 ThromboGenics Key News
7.11 Ionis Pharmaceuticals
7.11.1 Ionis Pharmaceuticals Corporate Summary
7.11.2 Ionis Pharmaceuticals Business Overview
7.11.3 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Major Product Offerings
7.11.4 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Ionis Pharmaceuticals Key News
7.12 GlycoMimetics
7.12.1 GlycoMimetics Corporate Summary
7.12.2 GlycoMimetics Business Overview
7.12.3 GlycoMimetics Venous Thromboembolism Therapeutics Major Product Offerings
7.12.4 GlycoMimetics Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.12.5 GlycoMimetics Key News
7.13 BioInvent International
7.13.1 BioInvent International Corporate Summary
7.13.2 BioInvent International Business Overview
7.13.3 BioInvent International Venous Thromboembolism Therapeutics Major Product Offerings
7.13.4 BioInvent International Venous Thromboembolism Therapeutics Revenue in Global Market (2017-2022)
7.13.5 BioInvent International Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Venous Thromboembolism Therapeutics Market Opportunities & Trends in Global Market
Table 2. Venous Thromboembolism Therapeutics Market Drivers in Global Market
Table 3. Venous Thromboembolism Therapeutics Market Restraints in Global Market
Table 4. Key Players of Venous Thromboembolism Therapeutics in Global Market
Table 5. Top Venous Thromboembolism Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Venous Thromboembolism Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Venous Thromboembolism Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Venous Thromboembolism Therapeutics Product Type
Table 9. List of Global Tier 1 Venous Thromboembolism Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Venous Thromboembolism Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Venous Thromboembolism Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Venous Thromboembolism Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Venous Thromboembolism Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Venous Thromboembolism Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Venous Thromboembolism Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Venous Thromboembolism Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Venous Thromboembolism Therapeutics Product Offerings
Table 32. Johnson & Johnson Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Venous Thromboembolism Therapeutics Product Offerings
Table 35. Sanofi Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim Corporate Summary
Table 37. Boehringer Ingelheim Venous Thromboembolism Therapeutics Product Offerings
Table 38. Boehringer Ingelheim Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Daiichi Sankyo Corporate Summary
Table 40. Daiichi Sankyo Venous Thromboembolism Therapeutics Product Offerings
Table 41. Daiichi Sankyo Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Bristol-Myers Squibb (BMS) Corporate Summary
Table 43. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Product Offerings
Table 44. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Bayer HealthCare Corporate Summary
Table 46. Bayer HealthCare Venous Thromboembolism Therapeutics Product Offerings
Table 47. Bayer HealthCare Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Venous Thromboembolism Therapeutics Product Offerings
Table 50. Pfizer Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Leo Pharma Corporate Summary
Table 52. Leo Pharma Venous Thromboembolism Therapeutics Product Offerings
Table 53. Leo Pharma Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Portola Pharmaceuticals Corporate Summary
Table 55. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Product Offerings
Table 56. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. ThromboGenics Corporate Summary
Table 58. ThromboGenics Venous Thromboembolism Therapeutics Product Offerings
Table 59. ThromboGenics Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Ionis Pharmaceuticals Corporate Summary
Table 61. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Product Offerings
Table 62. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. GlycoMimetics Corporate Summary
Table 64. GlycoMimetics Venous Thromboembolism Therapeutics Product Offerings
Table 65. GlycoMimetics Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. BioInvent International Corporate Summary
Table 67. BioInvent International Venous Thromboembolism Therapeutics Product Offerings
Table 68. BioInvent International Venous Thromboembolism Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Venous Thromboembolism Therapeutics Segment by Type in 2021
Figure 2. Venous Thromboembolism Therapeutics Segment by Application in 2021
Figure 3. Global Venous Thromboembolism Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Venous Thromboembolism Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Venous Thromboembolism Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Venous Thromboembolism Therapeutics Revenue in 2021
Figure 8. By Type - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Venous Thromboembolism Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Venous Thromboembolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Daiichi Sankyo Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bayer HealthCare Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Leo Pharma Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ThromboGenics Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. GlycoMimetics Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. BioInvent International Venous Thromboembolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)